Ipamorelin is a synthetic growth hormone secretagogue — a peptide that nudges your pituitary to release more growth hormone — studied for lean mass support, sleep quality, and recovery. At TelosRX, ipamorelin protocols are available subject to medical approval by a licensed provider.
Unlike human growth hormone injections, ipamorelin doesn’t spike cortisol, prolactin, or appetite. That selectivity is what makes it one of the more studied GH secretagogues. It’s not FDA-approved, it’s not a miracle compound, and it works best alongside intentional training and nutrition — but the science behind how it works is solid enough to be worth understanding.
Here’s how to use ipamorelin correctly: mechanism, dosing, timing, cycling, what to expect, and what to watch for.
Step 1: Understand What Ipamorelin Actually Does
Before adjusting dose or timing, understand the mechanism — it determines every practical decision that follows.
Ipamorelin is a pentapeptide (five amino acids) that binds the ghrelin/GH secretagogue receptor (GHSR-1a) on the pituitary gland. When it binds, the pituitary releases a pulse of growth hormone. That GH then circulates and signals the liver to produce IGF-1 (insulin-like growth factor 1), which carries out most of GH’s downstream effects: protein synthesis, fat metabolism, cell repair, and tissue regeneration.
A foundational study in European Journal of Endocrinology established ipamorelin as “the first selective growth hormone secretagogue” — selective because, unlike older GH secretagogues, it releases GH without significantly raising cortisol or prolactin. This profile matters clinically: cortisol elevation blunts muscle protein synthesis, so an agent that avoids it is meaningfully cleaner.
Ipamorelin used in compounded form is not FDA-approved. All use requires evaluation and approval by a licensed provider.
Step 2: Confirm You’re a Candidate Before Starting
Not everyone should use ipamorelin. A provider evaluation — which at TelosRX happens asynchronously, without a live appointment — reviews your history for these considerations:
- Appropriate use case: GH secretagogues are studied for GH deficiency, age-related GH decline, body composition support, and recovery. Recreational use without a clinical rationale is a different conversation.
- Active malignancy: Growth hormone can stimulate cell proliferation. Anyone with active cancer or a personal history of hormone-sensitive cancers requires careful provider evaluation.
- Diabetes and insulin resistance: GH has counter-regulatory effects on insulin. People with poorly controlled blood sugar need closer monitoring during any GH secretagogue protocol.
- Pregnancy or breastfeeding: GH secretagogues are not studied in these populations; avoid without specific provider clearance.
- Sleep apnea: GH therapy can worsen sleep apnea in some individuals. Relevant history should be disclosed during intake.
Approval is not guaranteed. A completed evaluation by a licensed provider is required before any prescription is issued.
Step 3: Know the Standard Dosing Range
Ipamorelin is administered via subcutaneous injection. Dosing protocols studied in research and used in clinical practice generally fall within this range:
| Parameter | Typical Range | Notes |
|---|---|---|
| Dose per injection | 100–300 mcg | Most protocols start at 100–200 mcg; higher doses offer diminishing returns in some individuals |
| Frequency | 1–3 times daily | Once daily (bedtime) is common for beginners; twice or three times daily increases total GH output |
| Best timing | Fasted state, before bed or post-workout | Elevated blood sugar blunts GH release — take 60–90 min after last meal |
| Half-life | ~2 hours | Short half-life = pulsatile GH release, which mimics natural physiology |
| Cycle length | 8–16 weeks | Followed by an off-period; protocols vary by provider recommendation |
These are not universal prescriptions. Your provider-issued protocol governs your specific dose, frequency, and cycle length. Follow it, not a generic guide.
Thinking about starting an ipamorelin protocol? Begin your private evaluation at TelosRX — no live call required. A licensed provider reviews your intake and labs asynchronously and determines whether you qualify.
Step 4: Learn Proper Injection Technique
Ipamorelin is administered subcutaneously — into the fat layer just beneath the skin, not into muscle.
- Wash your hands thoroughly before handling the vial or syringe.
- Wipe the vial cap with an alcohol swab and allow it to dry for 10–15 seconds.
- Draw the correct dose using an insulin syringe (29–31 gauge, 0.5 mL). Draw air equal to your dose volume, inject into the vial, then withdraw the peptide.
- Choose an injection site — abdomen (2 inches from the navel), outer thigh, or upper arm. Rotate sites with each injection to reduce the risk of local tissue irritation.
- Pinch a fold of skin, insert the needle at a 45–90 degree angle, and inject slowly.
- Remove the needle, apply light pressure (do not rub — rubbing disperses the peptide too quickly).
- Dispose of the syringe in a sharps container. Never recap used needles.
Your provider may supply additional technique guidance specific to your protocol. Follow their instructions over general guidance when the two differ.
Step 5: Time Your Injections to Maximize GH Pulse
Timing matters more with ipamorelin than with most compounds because GH release is pulsatile and blunted by food — especially high-carbohydrate and high-fat meals. Here’s how to get the most from each injection:
- Bedtime dose (most common): Inject 60–90 minutes after your last meal and 30 minutes before bed. Your body releases the largest natural GH pulse during deep sleep (N3 stage). Ipamorelin at this time stacks with that pulse, amplifying the signal.
- Post-workout dose (if using twice daily): GH is naturally elevated 30–60 minutes post-exercise. An ipamorelin injection 30 minutes after a training session — in a fasted or low-insulin state — can amplify this. Ensure at least 60 minutes have passed since eating.
- Morning dose (if using three times daily): Inject upon waking, before eating. The fasted morning state is a naturally low-insulin window.
The core rule across all timing windows: inject in a low-insulin state. Blood sugar elevates insulin, and elevated insulin suppresses GH release — directly undermining what the peptide is trying to do.
Step 6: Combine with Supporting Peptides (If Prescribed)
Ipamorelin is commonly prescribed as a standalone protocol. It is also studied in combination with CJC-1295, a GHRH (growth hormone-releasing hormone) analogue. The two work through complementary pathways:
- Ipamorelin mimics ghrelin and stimulates GH release via the GHSR receptor
- CJC-1295 mimics GHRH and signals the pituitary to be more responsive to GH-releasing stimuli
When used together, the two create a larger, more sustained GH pulse than either does alone. A review in the Journal of Clinical Medicine discusses the role of GH secretagogues including ipamorelin in the management of body composition in hypogonadal males, noting their additive effects when combined with GHRH analogues.
The CJC-1295/ipamorelin stack is one of the more commonly prescribed growth hormone peptide protocols. For a deeper look at that combination, see our guide on CJC-1295 and Ipamorelin: Growth Hormone Peptide Stack Research.
Whether you use ipamorelin alone or in combination is a provider decision based on your evaluation — not a self-selection.
Step 7: Know What a Typical Timeline Looks Like
Ipamorelin is not a rapid-onset compound. GH works slowly on body composition and tissue repair. Preclinical and clinical data suggest effects emerge on these rough timelines:
- Weeks 1–2: Sleep quality changes are often the first reported effect. Deeper sleep, more vivid dreaming, and improved morning energy are common early observations.
- Weeks 3–6: Mild improvements in recovery between training sessions and subtle changes in how full you feel after meals. Some people notice mild fluid retention (usually temporary).
- Weeks 6–12: Body composition changes become more perceptible — gradual improvement in lean mass and reduction in subcutaneous fat, particularly when combined with consistent resistance training and adequate protein intake.
- Months 3–6: Cumulative effects on skin quality, connective tissue, and body composition are typically most visible in this window if the protocol is sustained.
Results vary considerably by individual, dosing protocol, training habits, and nutrition. These timelines are not guaranteed outcomes.
Step 8: Monitor for Side Effects
Ipamorelin has a favorable side effect profile relative to synthetic hGH and older secretagogues — but it is not without risk. Watch for these and report them to your provider:
- Water retention: GH promotes water retention, particularly in the early weeks. Mild ankle or hand swelling is common and typically resolves.
- Headache or head rush: Reported at higher doses; usually resolves within a few weeks as the body adjusts.
- Tingling in hands or feet (carpal-tunnel-like symptoms): A known GH-class side effect, particularly at higher doses. Dose reduction usually resolves it.
- Injection site reactions: Redness, mild swelling, or irritation at the injection site. Rotate sites and use proper technique to minimize.
- Blood sugar effects: GH has counter-regulatory effects on insulin. People with diabetes or insulin resistance should monitor blood sugar more closely during a GH secretagogue protocol.
If side effects are persistent or concerning, contact your provider through the TelosRX platform. Do not adjust your dose independently.
Step 9: Store Your Peptide Correctly
Ipamorelin is a peptide — it’s fragile compared to small-molecule drugs and degrades under improper storage conditions.
- Lyophilized (powder) form: Store at room temperature or refrigerated; protect from light and heat; can remain stable for months when stored correctly
- Reconstituted (after adding bacteriostatic water): Refrigerate at 2–8°C (36–46°F); do not freeze; use within 28–30 days of reconstitution
- During travel: Keep refrigerated when possible; brief room-temperature exposure (a few hours) is generally acceptable, but sustained heat degrades the peptide
Your dispensing pharmacy includes specific storage instructions. Follow those over general guidance.
Frequently Asked Questions
What is ipamorelin and how does it work?
Ipamorelin is a synthetic peptide that binds the ghrelin/GH secretagogue receptor on the pituitary gland, triggering a pulse of growth hormone release. That GH then drives the liver to produce IGF-1, which supports protein synthesis, fat metabolism, and tissue repair. It is not FDA-approved, and use requires evaluation and approval by a licensed provider.
Is ipamorelin FDA-approved?
No. Ipamorelin is not FDA-approved for any clinical indication. When used in compounded form, it is prepared under federal compounding regulations. A provider-issued prescription is required before dispensing. TelosRX does not dispense without a completed clinical evaluation and provider approval.
What dose of ipamorelin is used?
Research and clinical protocols typically use 100–300 mcg per injection, administered 1–3 times daily via subcutaneous injection. Your provider prescribes your specific dose based on your health history and evaluation findings. Do not self-adjust dose without provider guidance.
When is the best time to take ipamorelin?
The optimal timing is in a low-insulin state: 60–90 minutes after a meal, typically before bed (to align with the natural deep-sleep GH pulse) or post-workout. High blood sugar at the time of injection blunts GH release. Follow your provider’s specific timing recommendations.
How long before I see results from ipamorelin?
Sleep quality changes are often the earliest reported effect, sometimes within 1–2 weeks. Body composition changes — gradual lean mass support and fat reduction — typically become noticeable after 6–12 weeks of consistent use alongside resistance training and adequate protein. Individual results vary and are not guaranteed.
Can ipamorelin be used without CJC-1295?
Yes. Ipamorelin is studied and used as a standalone protocol. It is also commonly stacked with CJC-1295 for a more amplified GH pulse. Whether to use it alone or in combination is a provider decision based on your clinical profile, not a personal preference call.
What are the side effects of ipamorelin?
Common side effects include temporary water retention, mild headache, injection-site reactions, and — at higher doses — tingling in the hands (carpal-tunnel-like). Ipamorelin does not significantly raise cortisol or prolactin, which distinguishes it from older GH secretagogues. Persistent or concerning side effects should be reported to your provider.
Is ipamorelin safe for long-term use?
Long-term human safety data for ipamorelin is limited. Clinical protocols typically run 8–16 weeks followed by an off-period. Any long-term use should be under active provider supervision, with periodic lab monitoring. Individual risk depends on your baseline health, dose, and concurrent medications or conditions.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.